Agile Thrpe (AGRX)

2.0700 -0.0500 (-2.36%)
Closed USD Disclaimer

Agile Thrpe Company Profile

Equity Type
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a prescription combined hormonal contraceptive patch, which contains the active ingredients ethinyl estradiol (EE), which is a synthetic estrogen and levonorgestrel (LNG), which is a type of progestin. Twirla delivers 30 micrograms of EE per day, a dose of EE consistent with the dose delivered by many commonly prescribed oral contraceptives. The Company commercializes Twirla in the United States. Twirla leverages the Company’s transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability.
Contact Information
Princeton,08540 United States
609 683 1880
Top Executives
Frank Z. Stanczyk 0 0000 Member of Scientific Advisory Board
David F. Archer 0 0000 Member of Scientific Advisory Board
Carolyn Westhoff 0 0000 Member of Scientific Advisory Board
Sharon Barbari 67 2020 Independent Director
Seth H. Z. Fischer 66 2016 Lead Independent Director
Yuriy A. Prilutskiy 0 0000 Board Observer
John W. Hubbard 66 2014 Independent Director
Alfred F. Altomari 64 2004 Chairman, President & CEO
Sandra Carson 69 2020 Independent Director
Josephine Torrente 57 2021 Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.